Dr. Nabil Noureddin (Medicine) published his manuscript, “Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass?” in the Hepatology Communications Journal. Noureddin is the first author on this editorial that emphasized how MRI techniques can accurately diagnose and stage Nonalcoholic Steatohepatitis (NASH) and are useful in monitoring disease response. The authors reached that conclusion after literature review and after commenting on a longitudinal study that followed a cohort of patients who had bariatric surgery and underwent baseline and one-year liver biopsy as well as multiparametric MRE. They also suggested potential improvements on NASH clinical trials to better utilize the MRI techniques in these trials. Noureddin is the chief resident in the department of internal medicine.
